EUCTR2010-018303-28-FR
Active, not recruiting
Not Applicable
Etude pilote des signes électro-encéphalographiques de réveil secondaire à l’injection de sugammadex : évaluation par l’enregistrement de l’Index Bispectral et du NeuroSENSE (étude prospective, randomisée, monocentrique et réalisée en double aveugle) - Suggamadex-Réveil
DrugsBridion
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Hopital Foch
- Status
- Active, not recruiting
- Last Updated
- 14 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients scheduled for general anesthesia
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range
- •F.1\.3 Elderly (\>\=65 years) yes
- •F.1\.3\.1 Number of subjects for this age range
Exclusion Criteria
- •\- Age under 18 years
- •\- Pregnancy, non menopausal woman
- •\- Allergy to propofol, soybeans or peanuts
- •\- Allergy to sufentanil, remifentanil, morphine, or to a component
- •\- Hypersensibility to sufentanil, remifentanil or to a derivate of fentanyl
- •\- Allergy to rocuronium or to bromure ion
- •\- History of a central neurological disorder or of a lesion cerebral
- •\- Patients receiving a psychotropic treatment
- •\- Presence of a pace\-maker
- •\- Hypersensibility to sugammadex or to a component
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Detection of electroencephalographic (EEG) activity expressing burning pain by the thermal grill illusiohealthy personJPRN-UMIN000042334kio university20
Completed
Phase 2
A Pilot Electroencephalography (EEG) Study to Evaluate the Effect of CT1812 Treatment on Synaptic Activity in Subjects With Mild to Moderate Alzheimer*s DiseaseAlzheimer's DiseaseDementia10012272NL-OMON54794Julius Clinical16
Active, not recruiting
Phase 1
A Pilot Clinical Study to evaluate the effect of CT1812 in subjects with Mild to Moderate Alzheimer’s Disease Using EEGMild to Moderate Alzheimer’s DiseaseMedDRA version: 20.0 Level: LLT Classification code 10001896 Term: Alzheimer's disease System Organ Class: 100000004852Therapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2019-003552-36-NLCognition Therapeutics, Inc.16
Completed
Not Applicable
Electroencephalographic and peripheral physiological correlates of post-traumatic stress disorder as an efficacy indicator of a cognitive-behavioural treatment programISRCTN66456536German Research Foundation (Deutsche Forschungsgemeinsschaft) (DFG)42
Active, not recruiting
Not Applicable
Measuring brain activity by in-ear electrodes in hospitalised patientsISRCTN25897827Imperial College London30